marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Interpace Biosciences Financial Ratios 2011-2024 | IDXG
Annual Financial Ratios Interpace Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
7.4 | -0.2 | -1.5 | -0.6 | -1.1 | -2.1 | -1.4 | -0.9 | -0.4 | -1.4 | -19.0 | -4.4 | -8.0 |
P/S |
0.1 | 0.1 | 2.7 | 0.5 | 1.2 | 1.2 | 1.1 | 0.6 | 0.4 | 0.2 | 0.6 | 0.9 | 0.6 |
EPS |
0.2 | -5.2 | -3.6 | -7.3 | -7.2 | -4.5 | -8.0 | -120.9 | -88.0 | -112.5 | -0.3 | -1.8 | -0.8 |
EV (Enterprise Value) |
30.6 M | 32.3 M | 53.9 M | 41.7 M | 82.3 M | 34.8 M | 15.9 M | 42.2 M | 50.5 M | 95.9 M | 77.5 M | 102 M | 85.3 M |
EBITDA per Share |
0.89 | -0.25 | -0.23 | -5.48 | -4.28 | -1.45 | -3.42 | -40.7 | -150 | -66 | -19.4 | 7.03 | -11.5 |
EV/EBITDA |
-6.0 | -0.8 | -1.8 | -4.7 | -0.4 | -2.0 | -0.2 | -2.8 | -14.3 | 58.1 | -19.0 | ||
PEG |
-0.12 | -0.01 | 0.34 | -0.63 | -0.02 | 0.05 | 0.02 | 0.02 | 0.01 | -0.01 | 0.23 | -0.04 | -0.11 |
P/B |
-0.4 | -0.3 | 5.4 | 0.9 | 2.2 | 0.8 | 0.4 | 1.2 | 0.3 | 1.2 | 2.7 | 3.2 | 1.6 |
P/CF |
1.6 | -0.6 | -2.6 | -1.0 | -1.5 | -2.8 | -1.1 | -0.8 | -0.2 | -0.8 | -16.2 | -9.9 | 58.3 |
ROE % |
-1.30 | 34.81 | 35.23 | -151.56 | -205.18 | -37.01 | -30.64 | -127.58 | -87.10 | -79.88 | -14.06 | -71.64 | -20.02 |
ROA % |
6.16 | -137.42 | -38.89 | -57.90 | -38.71 | -25.16 | -22.79 | -19.94 | -16.77 | -13.87 | -6.61 | -32.54 | -10.51 |
ROCE % |
-4.55 | 5.73 | 14.94 | -96.75 | -39.10 | -18.39 | -18.99 | -43.74 | -61.01 | -12.89 | -11.36 | -2.40 | -6.99 |
Current Ratio |
0.5 | 0.5 | 1.1 | 0.8 | 0.9 | 2.1 | 2.4 | 0.3 | 0.8 | 1.3 | 2.0 | 2.0 | 1.7 |
DSO |
45.5 | 54.1 | 276.7 | 90.4 | 154.6 | 158.1 | 78.9 | 70.7 | 149.1 | 43.9 | 25.2 | 36.4 | 28.4 |
DIO |
27.4 | 27.5 | 36.7 | 34.6 | 41.9 | - | - | - | - | - | - | - | - |
DPO |
29.0 | 32.5 | 75.0 | 76.0 | 110.5 | 37.9 | 19.4 | 127.8 | 82.4 | 15.5 | 6.8 | 12.4 | 12.1 |
Operating Cycle |
72.9 | 81.5 | 313.4 | 125.0 | 196.5 | 158.1 | 78.9 | 70.7 | 149.1 | 43.9 | 25.2 | 36.4 | 28.4 |
Cash Conversion Cycle |
43.9 | 49.0 | 238.3 | 49.0 | 85.9 | 120.2 | 59.5 | -57.2 | 66.7 | 28.4 | 18.4 | 24.0 | 16.3 |
All numbers in USD currency
Quarterly Financial Ratios Interpace Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.29 | 0.47 | 0.11 | - | -0.14 | 0.04 | 0.08 | - | -3.35 | -0.93 | -0.53 | - | -0.85 | -0.84 | -1.03 | - | -1.54 | -1.38 | -2.38 | - | -1.97 | -1.39 | -0.94 | - | -0.11 | -0.07 | -0.11 | - | -0.15 | -0.65 | 0.56 | - | -43.97 | -1.29 | -2.69 | - | -0.31 | -0.46 | -0.26 | - | -0.29 | -0.18 | -0.11 | - | -0.15 | -0.06 | 0.14 | - | -0.07 | -0.03 | -0.02 | - | -0.01 | -0.06 | -0.04 |
EBITDA per Share |
- | - | 0.21 | - | 0.04 | 0.26 | 0.24 | - | -0.11 | -0.38 | -0.05 | - | 0.61 | 0.01 | -0.56 | - | -0.47 | -0.76 | -1.26 | - | -1.04 K | -0.9 | -0.63 | - | 4.08 | -0.01 | -0.09 | - | -0.01 | -0.17 | 1.09 | - | -1.65 | -0.28 | -1.43 | - | -0.18 | -0.34 | -0.33 | - | -0.13 | -0.02 | - | - | -0.08 | -0.02 | 0.17 | - | 0.05 | 0.05 | 0.02 | - | 0.18 | 0.03 | -0.04 |
ROE % |
-5.50 | -2.30 | 0.91 | 0.14 | 23.20 | 45.29 | 53.79 | 36.35 | 45.56 | 31.71 | 33.12 | 31.63 | 59.63 | 71.85 | 81.41 | 90.95 | 301.02 | 445.82 | 545.06 | 596.99 | 331.09 | 155.35 | 30.86 | -53.35 | -34.04 | -33.08 | -43.03 | -18.71 | -141.25 | -255.26 | -282.78 | -247.18 | -288.63 | -207.55 | -221.43 | -134.28 | -156.41 | -137.09 | -92.87 | -43.36 | -49.95 | -34.40 | -23.91 | -2.76 | -5.62 | -1.89 | -0.41 | -4.86 | -5.19 | -2.67 | -2.95 | -2.77 | -0.34 | -1.50 | -0.92 |
ROA % |
24.56 | 11.13 | -3.67 | -1.00 | -93.91 | -182.50 | -194.70 | -109.86 | -118.70 | -34.63 | -31.51 | -26.41 | -44.23 | -49.04 | -53.28 | -57.90 | -60.77 | -61.57 | -59.64 | -51.88 | -45.00 | -37.01 | -30.85 | -31.16 | -23.69 | -23.58 | -31.37 | -13.92 | -33.07 | -45.89 | -40.77 | -38.64 | -46.62 | -35.45 | -39.70 | -25.86 | -29.70 | -25.56 | -16.79 | -7.53 | -10.63 | -9.88 | -8.87 | -1.30 | -2.60 | -0.80 | -0.08 | -2.21 | -2.38 | -1.26 | -1.49 | -1.45 | -0.18 | -0.79 | -0.49 |
ROCE % |
- | - | - | - | 1.27 | 2.53 | 6.52 | 7.46 | 12.18 | 15.64 | 19.77 | 24.44 | 45.09 | 61.01 | 72.74 | 66.40 | 225.65 | 364.26 | 463.79 | 1687.04 | 1680.50 | 1514.70 | 1390.23 | -20.35 | -27.36 | -27.83 | -30.88 | -6.78 | -106.12 | -198.46 | -216.05 | -158.93 | -190.43 | -122.59 | -132.27 | -98.79 | -109.73 | -89.17 | -57.38 | -15.98 | -21.43 | -15.94 | -14.56 | -1.72 | -3.51 | 0.14 | 1.64 | -3.07 | -2.78 | -0.70 | -1.54 | -3.37 | 0.29 | -1.59 | -2.06 |
Current Ratio |
0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.4 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 2.0 | 3.1 | 3.1 | 3.1 | 2.7 | 3.9 | 3.9 | 3.9 | 0.7 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 2.1 | 2.1 | 2.1 | 2.1 |
DSO |
50.1 | 42.5 | 44.4 | - | 52.1 | 42.4 | 45.3 | - | 404.7 | 319.3 | 221.5 | - | 78.4 | 62.1 | 73.7 | - | 88.8 | 134.5 | 92.5 | - | 122.1 | 150.4 | 150.5 | - | 150.4 | 157.3 | 122.6 | - | 74.6 | 81.4 | 74.2 | - | 71.0 | 72.4 | 84.0 | - | 441.2 | 298.3 | 143.2 | - | 26.5 | 24.6 | 14.5 | - | 6.5 | 5.9 | 13.9 | - | 30.7 | 35.1 | 29.3 | - | 24.4 | 22.8 | - |
DIO |
23.4 | 23.6 | 25.9 | - | 25.1 | 25.6 | 28.4 | - | 42.9 | 52.0 | 40.3 | - | 57.1 | 35.3 | 36.7 | - | 36.0 | 48.6 | 28.9 | - | 34.4 | 54.9 | 31.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
33.0 | 30.9 | 31.6 | - | 33.6 | 35.6 | 31.2 | - | 65.6 | 95.6 | 74.4 | - | 61.8 | 43.2 | 64.5 | - | 79.2 | 106.9 | 68.8 | - | 88.9 | 141.8 | 100.4 | - | 35.0 | 43.0 | 25.6 | - | 17.2 | 19.0 | 70.0 | - | 115.0 | 115.2 | 150.4 | - | 79.1 | 76.9 | 107.9 | - | 16.1 | 15.2 | 11.1 | - | 50.7 | 43.6 | 63.0 | - | 75.9 | 76.0 | 75.0 | - | 90.5 | 66.2 | - |
Operating Cycle |
73.4 | 66.1 | 70.2 | - | 77.2 | 68.0 | 73.7 | - | 447.6 | 371.3 | 261.8 | - | 135.5 | 97.4 | 110.4 | - | 124.9 | 183.2 | 121.4 | - | 156.6 | 205.4 | 182.2 | - | 150.4 | 157.3 | 122.6 | - | 74.6 | 81.4 | 74.2 | - | 71.0 | 72.4 | 84.0 | - | 441.2 | 298.3 | 143.2 | - | 26.5 | 24.6 | 14.5 | - | 6.5 | 5.9 | 13.9 | - | 30.7 | 35.1 | 29.3 | - | 24.4 | 22.8 | - |
Cash Conversion Cycle |
40.5 | 35.2 | 38.6 | - | 43.5 | 32.4 | 42.5 | - | 382.0 | 275.7 | 187.4 | - | 73.7 | 54.2 | 45.9 | - | 45.6 | 76.2 | 52.6 | - | 67.7 | 63.6 | 81.9 | - | 115.4 | 114.3 | 96.9 | - | 57.4 | 62.4 | 4.2 | - | -44.0 | -42.9 | -66.4 | - | 362.1 | 221.4 | 35.3 | - | 10.4 | 9.3 | 3.4 | - | -44.2 | -37.7 | -49.1 | - | -45.2 | -40.9 | -45.7 | - | -66.2 | -43.5 | - |
All numbers in USD currency